Covered recipient · General Payments record
MARIED E CELKIS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$1,147.63
- Reported across 52 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $774.47 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $217.71 | 9 |
| GlaxoSmithKline, LLC. | $164.61 | 3 |
| Otsuka America Pharmaceutical, Inc. | $142.87 | 2 |
| PFIZER INC. | $79.10 | 4 |
| Lilly USA, LLC | $55.55 | 3 |
| Amgen Inc. | $29.96 | 2 |
| Lundbeck LLC | $18.65 | 1 |
| Acerta Pharma LLC | $17.11 | 1 |
| ABBVIE INC. | $17.01 | 1 |
| VIVUS LLC | $16.70 | 1 |
| Medtronic, Inc. | $15.20 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.01 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103431482 | CMS |
| Amgen Inc. | $15.73 | 07/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117220604 | CMS |
| Amgen Inc. | $14.23 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117220606 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.11 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104624452 | CMS |
| GlaxoSmithKline, LLC. | $122.40 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116317050 | CMS |
| GlaxoSmithKline, LLC. | $23.95 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116237597 | CMS |
| GlaxoSmithKline, LLC. | $18.26 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116286517 | CMS |
| Lilly USA, LLC | $20.17 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135166850 | CMS |
| Lilly USA, LLC | $20.00 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135166459 | CMS |
| Lilly USA, LLC | $15.38 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135148422 | CMS |
| Lundbeck LLC | $18.65 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145903506 | CMS |
| Medtronic, Inc. | $15.20 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117102845 | CMS |
| Novo Nordisk Inc | $7.42 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097278508 | CMS |
| Novo Nordisk Inc | $19.72 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096746107 | CMS |
| Novo Nordisk Inc | $20.48 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097697524 | CMS |
| Novo Nordisk Inc | $12.35 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097331263 | CMS |
| Novo Nordisk Inc | $7.68 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097642456 | CMS |
| Novo Nordisk Inc | $15.98 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096936813 | CMS |
| Novo Nordisk Inc | $6.87 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096896061 | CMS |
| Novo Nordisk Inc | $120.87 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097502780 | CMS |
| Novo Nordisk Inc | $6.34 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096874739 | CMS |
| Otsuka America Pharmaceutical, Inc. | $119.53 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118872742 | CMS |
| Otsuka America Pharmaceutical, Inc. | $23.34 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118872744 | CMS |
| PFIZER INC. | $21.12 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131054186 | CMS |
| PFIZER INC. | $18.10 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131164608 | CMS |
| PFIZER INC. | $20.65 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131858823 | CMS |
| PFIZER INC. | $19.23 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131144887 | CMS |
| VIVUS LLC | $16.70 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129415006 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.